Joanna Chon - Academia.edu (original) (raw)
Papers by Joanna Chon
The Journal of Urology, Jun 1, 1999
Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n ... more Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n = 31), and men treated with terazosin (n = 42) and doxazosin (n = 61) for the relief of the obstructive symptoms. Terazosin (1 to 10 mg./day) and doxazosin (2 to 8 mg./day) treatment varied ...
The Journal of Urology, Apr 1, 1999
The Journal of Urology, 1999
American Journal of Obstetrics and Gynecology, Dec 31, 2002
The Journal of Urology, 2000
The Journal of Urology, 1999
The Journal of Urology, 1999
The Journal of Urology, 1999
Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n ... more Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n = 31), and men treated with terazosin (n = 42) and doxazosin (n = 61) for the relief of the obstructive symptoms. Terazosin (1 to 10 mg./day) and doxazosin (2 to 8 mg./day) treatment varied ...
American Journal of Obstetrics and Gynecology, 2002
The Journal of Urology, 2002
The Journal of Urology, Jun 1, 1999
Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n ... more Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n = 31), and men treated with terazosin (n = 42) and doxazosin (n = 61) for the relief of the obstructive symptoms. Terazosin (1 to 10 mg./day) and doxazosin (2 to 8 mg./day) treatment varied ...
The Journal of Urology, Apr 1, 1999
The Journal of Urology, 1999
American Journal of Obstetrics and Gynecology, Dec 31, 2002
The Journal of Urology, 2000
The Journal of Urology, 1999
The Journal of Urology, 1999
The Journal of Urology, 1999
Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n ... more Cell proliferation and apoptosis were evaluated in BPH patients, an untreated (control) group (n = 31), and men treated with terazosin (n = 42) and doxazosin (n = 61) for the relief of the obstructive symptoms. Terazosin (1 to 10 mg./day) and doxazosin (2 to 8 mg./day) treatment varied ...
American Journal of Obstetrics and Gynecology, 2002
The Journal of Urology, 2002